FDA inspection
Bi-Coastal Pharma International: FDA inspection ending Sep 14, 2020
FDA inspection 1129470 · Voluntary Action Indicated (VAI) · Shrewsbury, NJ
Key facts
| Inspection ID | 1129470 |
|---|---|
| Firm | Bi-Coastal Pharma International |
| FEI number | 3013263547 |
| Address | 1161 Broad St Ste 216 |
| City | Shrewsbury |
| State | NJ |
| ZIP | 07702 |
| Country | United States |
| Fiscal year | 2020 |
| Inspection end date | Sep 14, 2020 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Bioresearch Monitoring |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data